Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia

Baqsimi (bak-SEE-mee) and Gvoke (JEE-vohk) are new glucagon Rxs that will be game changers for treating severe hypoglycemia.

Baqsimi is INTRANASAL glucagon. It's a ready-to-use powder sprayed in one nostril...and is absorbed without inhaling.

Gvoke is a SUBCUTANEOUS injection. It's already mixed and drawn up in a prefilled syringe. An auto-injector will be available next year.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals